Furthermore, DPI (diphenylene iodonium), a widely used NADPH oxidase inhibitor, has been found to have significant therapeutic effects in a number of inflammatory diseases, including liver disease, exothermia, and EAE [73–76], and now appears to have efficacy as a therapeutic to prevent DA neurodegeneration in PD (see below). This evidence concerns the gene FMO5 and Parkinson disease.